InflaRx N.V. (IFRX) vs MacroGenics, Inc. (MGNX)
A side-by-side comparison of InflaRx N.V. and MacroGenics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
IFRX
InflaRx N.V.
$1.63HealthcareDelayed quote: Oct 6, 2026, 12:00 PM EDT
MGNX
MacroGenics, Inc.
$3.72HealthcareDelayed quote: Oct 6, 2026, 12:00 PM EDT
Total return — IFRX vs MGNX
growth of $100 · dividends reinvested · last 9yIFRX -88.8% (-21.6%/yr)MGNX -79.8% (-16.3%/yr)MGNX compounded faster over this window
IFRX MGNX
IFRX vs MGNX: by the numbers
- •IFRX is the larger company ($240M vs $236M market cap).
- •Both run net losses; MGNX's is the smaller (-8.70% vs -155582.08% net margin).
Metrics side by side
Valuation
| Metric | IFRX | MGNX |
|---|---|---|
| P/S ratio | N/A | 1.41 |
| P/B ratio | 1.44 | 5.51 |
Profitability
| Metric | IFRX | MGNX |
|---|---|---|
| Gross margin | -24677.94% | 71.12% |
| Operating margin | -164525.50% | -48.72% |
| Net margin | -155582.08% | -8.70% |
| ROE | -27.27% | -34.04% |
| ROIC | -25.38% | -16.87% |
Growth (annualized)
| Metric | IFRX | MGNX |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 7.33% |
| Total return CAGR (5Y) | -7.34% | -28.42% |
Frequently asked
- How have IFRX and MGNX total returns compared?
- Over the past 5 years, IFRX delivered -7.34% and MGNX delivered -28.42% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.